| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Farxiga | |
| 3 | Generic Name | dapagliflozin | |
| 4 | Economics | Once part of BMY diabetes alliance | |
| 5 | MOA | SGLT2 inhibitor | |
| 6 | IP | 6515117 COM expires 2025 | |
| 7 | 10973836 MOU expires 2040! | ||
| 8 | Clinical Trials | ||
| 9 | Phase IIB vs metformin and placebo - 12-week study - ADA 2008 presentation | ||
| 10 | A1C reductions similar to metformin. |